GlobeNewswire Inc.··NaKyverna Bolsters Board With Beam, Karuna Executives Ahead of Cell Therapy Launch
Kyverna appoints two biotech executives to its board ahead of cell therapy commercialization. New directors bring expertise from Beam Therapeutics and Karuna Therapeutics.
BMYCELGrKYTXBEAMclinical developmentautoimmune diseases